Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)

NARecruitingINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
EpiDural HematomaTraumatic Brain Injury
Interventions
PROCEDURE

MMA embolization plus medical therapy

Patients assigned to the intervention group will receive endovascular embolization treatment within 2 hours after enrollment. Patients will receive the best conservative treatment recommended by the guidelines after MMA, and conservative treatment will be the same in both groups

DRUG

Medical therapy alone

Patients will receive the best conservative treatment recommended by the guidelines, and conservative treatment will be the same in both groups. Conservative treatment includes medication and general treatment. Drug therapy can be divided into hemostatic treatment, antihypertensive treatment, and symptomatic treatment. Specific local clinical diagnosis and treatment standards shall prevail or refer to corresponding clinical guidelines.

Trial Locations (1)

200433

RECRUITING

Changhai hospital, Shanghai

All Listed Sponsors
collaborator

The First People's Hospital of Changzhou

OTHER

lead

Changhai Hospital

OTHER